Associate Professor of Biomedical Engineering, Beijing University of Chemical technology, Beijing university of chemical technology, Chinaš
Zhao Yang is an Associate Professor in Biomedical Engineering at Beijing University of Chemical Technology, where he also directs the Research Center of Precision Medicine. His academic journey began at Jilin University, where he earned his Bachelor’s degree in Biochemistry and Molecular Biology. He later completed his Ph.D. at the Chinese Academy of Sciences. Zhao has significantly contributed to the field of precision oncology, focusing on cancer stem cells, biomarkers, and drug-targeted therapy.
Profile
Orcid
Education š
Zhao Yang obtained his Bachelor of Science in Biochemistry and Molecular Biology from Jilin University (2006-2010). He went on to complete his Ph.D. in the same field at the Chinese Academy of Sciences, specializing in infection and immunity (2010-2015).
Experience š¼
With extensive experience in precision medicine, Zhao is involved in cutting-edge research on the molecular mechanisms of cancer progression. He has led several major research projects, including studies on bladder cancer progression and prostate cancer malignancy. Zhao has also contributed to over 85 publications in reputable journals.
Research Interest š¬
Zhao Yang’s research focuses on precision oncology, particularly in understanding cancer stem cells, biomarkers, and drug-targeted therapies. His work includes studies on the molecular events in bladder cancer and prostate cancer, as well as research into novel cancer therapies using CRISPR-Cas systems and non-hepatic targeting nanozyme carriers.
Award š
Zhao Yang is a prominent researcher in the field of biomedical engineering and oncology. He is a contender for the Best Researcher Award, recognized for his outstanding contributions in precision medicine and cancer research, including the development of biomarkers and targeted therapies for various cancers.
Publication š
Bladder Cancer Early Progression Key Molecular Events Visualization and Clinical Application
Major Research Program of National Natural Science Foundation of China
Published: January 2024 | Link to publication
Mechanism Study of m5C Methyltransferase NSUN7 Driving Vascular Mimicry in Prostate Cancer
Biomedical Translational Engineering Research Center of Beijing University
Published: January 2023 | Link to publication
Research on Nucleic Acid Delivery of Non-hepatic Targeting Nanozyme Carriers
Open Competition for Nucleic Acid Drugs
Published: November 2022 | Link to publication
Screening of Methyltransferase KMT1A Inhibitors in Bladder Cancer Stem Cells
National Natural Science Foundation of China
Published: December 2021 | Link to publication
Conclusion
Dr. Zhao Yang’s work stands at the forefront of precision oncology, with significant advancements in cancer stem cell research, biomarkers, and novel therapeutic strategies. His research has already contributed valuable insights into cancer diagnosis and treatment, and with further industry collaborations and broader dissemination of his findings, he is poised for even greater accomplishments. Dr. Yang is undoubtedly a strong contender for the Excellence in Research award due to his innovative contributions to cancer research and therapeutic development. ššÆ